Frontiers in ophthalmologyPub Date : 2026-10-12eCollection Date: 2026-01-01DOI: 10.3389/fopht.2026.1961375
George Y X Kong, Algis Vingrys, Manisha Ambawat, Md Mahboob, Shakira Bano, Syril Dorairaj, Shibal Bhartiya
{"title":"Comparison of the Melbourne rapid fields-web device-independent online perimeter and the octopus 600 perimeter in glaucoma patients.","authors":"George Y X Kong, Algis Vingrys, Manisha Ambawat, Md Mahboob, Shakira Bano, Syril Dorairaj, Shibal Bhartiya","doi":"10.3389/fopht.2026.1961375","DOIUrl":"10.3389/fopht.2026.1961375","url":null,"abstract":"<p><strong>Introduction: </strong>The purpose of this study is to evaluate the agreement, repeatability, and testing efficiency of Melbourne Rapid Fields-Web (MRF-Web), a browser-based, device-independent perimeter, compared with the Octopus 600 perimeter in glaucoma patients.</p><p><strong>Methods: </strong>This retrospective, cross-sectional, single-center observational study included 113 patients undergoing routine visual field assessment for glaucoma or glaucoma suspicion at Marengo Asia Hospitals, Gurgaon, India. MRF-Web testing was performed on a calibrated 14-inch laptop with Hindi voice guidance. Agreement between MRF-Web and Octopus 600 for Mean Deviation (MD) and pattern-based global indices was assessed using intraclass correlation coefficients (ICCs) and Bland-Altman analysis. Test-retest repeatability was evaluated in 51 patients who underwent repeat MRF-Web testing.</p><p><strong>Results: </strong>MRF-Web showed strong group-level concordance with Octopus 600 for MD, with an ICC of 0.88 (95% CI, 0.81-0.92), Bland-Altman bias of -0.78 dB, and 95% limits of agreement from -4.72 to 3.17 dB. Concordance for the pattern-based indices was moderate, with an ICC of 0.72 (95% CI, 0.58-0.81), bias of -0.59 dB, and 95% limits of agreement from -4.41 to 3.24 dB. MRF-Web demonstrated good test-retest concordance, with an ICC of 0.86 (95% CI, 0.69-0.94). Mean per-eye test duration was significantly shorter with MRF-Web than with Octopus 600 (232.9 ± 49.8 versus 342.4 ± 94.4 seconds).</p><p><strong>Conclusions: </strong>MRF-Web demonstrated strong group-level concordance with Octopus 600 MD measurements and shorter per-eye testing times in this predominantly mild-disease cohort. The limits of agreement indicate that measurements from the two platforms should not be regarded as directly interchangeable, and further study is required in moderate and advanced glaucoma.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1961375"},"PeriodicalIF":2.4,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13697594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in ophthalmologyPub Date : 2026-10-09eCollection Date: 2026-01-01DOI: 10.3389/fopht.2026.1952678
Abdulrahman Kaki, Jumanah Qedair, Nouf Alzendi, Konrad Schargel
{"title":"Case Report: Successful needle revision of an encapsulated bleb following PAUL glaucoma Implant surgery in a pediatric patient.","authors":"Abdulrahman Kaki, Jumanah Qedair, Nouf Alzendi, Konrad Schargel","doi":"10.3389/fopht.2026.1952678","DOIUrl":"10.3389/fopht.2026.1952678","url":null,"abstract":"<p><strong>Claims of priority statement: </strong>After conducting a literature review in July 2026 through PubMed, Google Scholar, Cochrane, and Web of Science databases using the keywords (Bleb needling; Encapsulated bleb; Mitomycin C; PAUL Glaucoma Implant; Primary congenital glaucoma), we did not find any prior similar reports. Therefore, to the best of our knowledge, this is the first report of successful needling of the PAUL Glaucoma Implant in a child with primary congenital glaucoma.</p><p><strong>Purpose: </strong>To report the clinical outcomes of a minimally invasive, stepwise transconjunctival bleb needling with mitomycin C (MMC) to rescue a failing, encapsulated PAUL Glaucoma Implant (PGI) in a pediatric patient with refractory primary congenital glaucoma (PCG).</p><p><strong>Methods: </strong>A case report of a 9-year-old female patient with a complex surgical history, including bilateral deep sclerectomies and PGIs, who presented with uncontrolled left intraocular pressure (IOP) of 27 mmHg despite maximal medical therapy. Baseline B-scan ultrasonography and clinical examination confirmed a +1 encapsulated, loculated fluid collection surrounding the left implant plate. The patient underwent an uneventful, stepwise transconjunctival needle revision using a 27-gauge needle combined with a subconjunctival injection of a 0.3 mL mixture of 0.4 mg/mL MMC and 2% lidocaine to mechanically disrupt the fibrous capsule.</p><p><strong>Results: </strong>On postoperative day 1, the left IOP was 24 mmHg with a deep anterior chamber. At the 9-day follow-up, the left IOP dropped to 14-17 mmHg with the formation of a quiet, diffuse bleb. By 1.5 months postoperatively, excellent stabilization was achieved with a left IOP of 10 mmHg and best-corrected visual acuity maintained at 20/40 (isolated optotypes reaching 20/30). At the final follow-up (2 months and 11 days), the left IOP remained well-controlled at 13 mmHg. A secondary poor ocular surface with superficial punctate keratitis was successfully managed with aggressive topical lubrication.</p><p><strong>Conclusions: </strong>Transconjunctival bleb needling augmented with MMC is an effective, conservative alternative to full surgical revision or implant replacement for managing encapsulated, hypertensive drainage blebs following PGI surgery in pediatric patients.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1952678"},"PeriodicalIF":2.4,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13690671/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in ophthalmologyPub Date : 2026-10-09eCollection Date: 2026-01-01DOI: 10.3389/fopht.2026.1801651
R Mikal Lange, Tasneem P Sharma
{"title":"Natural compounds as potential countermeasures for spaceflight-associated neuro-ocular syndrome.","authors":"R Mikal Lange, Tasneem P Sharma","doi":"10.3389/fopht.2026.1801651","DOIUrl":"https://doi.org/10.3389/fopht.2026.1801651","url":null,"abstract":"<p><p>Spaceflight-Associated Neuro-Ocular Syndrome (SANS) is a complex and multifactorial condition most commonly observed following long-duration spaceflight. Clinical findings of SANS include optic disc edema, retinal nerve fiber layer swelling, globe flattening, chorioretinal folds, and hyperopic refractive shifts. As human space exploration extends toward prolonged missions such as Artemis and Mars expeditions, SANS represents a significant risk to astronaut health and mission success. Although headward fluid shifts, elevated intracranial pressure, venous outflow congestion, and lymphatic dysfunction have been implicated in SANS pathophysiology, no single unifying mechanism or universally effective countermeasure has been identified. Emerging evidence suggests that oxidative stress from galactic cosmic radiation, endothelial dysfunction, inflammation, mitochondrial injury, altered angiogenesis, and disruptions in one-carbon metabolism contribute meaningfully to SANS development. This review summarizes the clinical manifestations and proposed mechanisms underlying SANS and examines naturally occurring compounds with high therapeutic indices that target these pathways. Specifically, we review bilberry anthocyanins with French maritime pine bark extract, Ginkgo biloba extract, saffron/crocin, curcumin, coenzyme Q10, resveratrol, vitamin E, and B vitamins as potential supplemental approaches, highlighting their mechanisms of action and therapeutic efficacy when targeting terrestrial ocular diseases. While direct studies in spaceflight environments remain limited, these compounds demonstrate antioxidant, anti-inflammatory, neuroprotective, vasoregulatory, and metabolic effects relevant to SANS. Collectively, they represent promising adjunctive candidates within a multimodal preventative strategy aimed at mitigating SANS risk during long-duration spaceflight.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1801651"},"PeriodicalIF":2.4,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13691736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in ophthalmologyPub Date : 2026-10-07eCollection Date: 2026-01-01DOI: 10.3389/fopht.2026.1959492
Beatriz Cordón, Beatriz Pardiñas, Mónica Hernández, María Jesús Rodrigo, Elvira Mayordomo, Luis Emilio Pablo, Elena García-Martin
{"title":"Structural changes in the retinal layers of patients with Steinert disease.","authors":"Beatriz Cordón, Beatriz Pardiñas, Mónica Hernández, María Jesús Rodrigo, Elvira Mayordomo, Luis Emilio Pablo, Elena García-Martin","doi":"10.3389/fopht.2026.1959492","DOIUrl":"10.3389/fopht.2026.1959492","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to evaluate the different retinal layers of the posterior pole protocol and peripapillary areas in optical coherence tomography (OCT) to identify significant changes attributable to Steinert disease.</p><p><strong>Methods: </strong>We analyzed 128 eyes of healthy control subjects and 79 eyes of patients with Steinert disease. We performed the posterior pole and Nsite analytics peripapillary protocols on all subjects and compared thicknesses in the retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), retinal pigment epithelium (RPE), and complete retina (RETINA).</p><p><strong>Results: </strong>Patients with Steinert disease showed significant alterations in retinal layer thickness compared with age-matched controls. Overall, a generalized thickening of retinal layers was observed; significant thickening of the RNFL was also found in the temporal area of the optic nerve and in the papillomacular bundle, which comprises the retinal ganglion cell axons connecting the macula with the optic nerve.</p><p><strong>Conclusions: </strong>Steinert disease is associated with retinal structural alterations in retinal layer structure, OCT may provide potential structural markers of retinal involvement in Steinert disease.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1959492"},"PeriodicalIF":2.4,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13682967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149240519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in ophthalmologyPub Date : 2026-10-07eCollection Date: 2026-01-01DOI: 10.3389/fopht.2026.1901237
Celina Wang, Koushani Chakrabarty, Stephen D Anesi, Peter Y Chang
{"title":"Classification of cystoid macular edema status from retinal vasculitis fluorescein angiography images using a convolutional neural network.","authors":"Celina Wang, Koushani Chakrabarty, Stephen D Anesi, Peter Y Chang","doi":"10.3389/fopht.2026.1901237","DOIUrl":"10.3389/fopht.2026.1901237","url":null,"abstract":"<p><strong>Introduction: </strong>Cystoid macular edema (CME) is a vision-threatening complication of retinal vasculitis, a rare inflammatory disease for which large imaging datasets are difficult to obtain. Detection of CME on fluorescein angiography (FA) requires expert interpretation, motivating automated image-based approaches to support clinical decision-making. Deep learning methods, particularly convolutional neural networks (CNNs), have shown strong performance in medical image analysis but are constrained by limited labeled data in rare diseases. Transfer learning may mitigate this limitation by adapting pretrained models to small, task-specific datasets.</p><p><strong>Methods: </strong>We analyzed 207 de-identified late-phase 55° FA images from 117 patients with retinal vasculitis. The primary target was concurrent patient-level CME status, established through specialist review of clinical records and optical coherence tomography obtained at the same clinical visit as FA. A patient was classified as CME-positive when CME was present in at least one eye. An ImageNet-pretrained ResNet-18 was evaluated using five-fold nested, patient-level cross-validation. Within each outer-development cohort, 144 candidate configurations were compared by four-fold inner cross-validation and selected according to mean inner-validation AUROC. Each selected configuration was evaluated only on its corresponding untouched outer-test fold.</p><p><strong>Results: </strong>Across 117 pooled patient-level outer-test predictions, the model-selection pipeline achieved an AUROC of 0.708 (95% CI, 0.610-0.802), an AUPRC of 0.626 (95% CI, 0.493-0.755), and an accuracy of 0.726 (95% CI, 0.641-0.803). Sensitivity was 0.694 (95% CI, 0.558-0.822), specificity was 0.750 (95% CI, 0.643-0.853), and the F1 score was 0.680 (95% CI, 0.563-0.780). Exploratory Grad-CAM analysis visualized regions associated with model predictions.</p><p><strong>Discussion: </strong>The nested model-selection pipeline showed moderate discrimination with a relatively balanced operating profile and slightly higher specificity than sensitivity. Clinically relevant false-positive and false-negative errors, together with the absence of external validation, preclude clinical deployment.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1901237"},"PeriodicalIF":2.4,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13683005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149240464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in ophthalmologyPub Date : 2026-10-05eCollection Date: 2026-01-01DOI: 10.3389/fopht.2026.1953940
Mohammad W Awlad Mohammad, Basel Bader, Mohammad Fuad Sayes, Alhareth M Amro, Toqa W Awlad Mohammad, Essa Hasheem, Mohammad Amro, Darwish M Mosameh, Dania Amwas, Abdallah Qawasmeh, Farid K Abu Sham'a
{"title":"Knowledge gaps and practices for glaucoma among adults in Palestine: a cross-sectional study.","authors":"Mohammad W Awlad Mohammad, Basel Bader, Mohammad Fuad Sayes, Alhareth M Amro, Toqa W Awlad Mohammad, Essa Hasheem, Mohammad Amro, Darwish M Mosameh, Dania Amwas, Abdallah Qawasmeh, Farid K Abu Sham'a","doi":"10.3389/fopht.2026.1953940","DOIUrl":"10.3389/fopht.2026.1953940","url":null,"abstract":"<p><strong>Background: </strong>Glaucoma is a leading cause of irreversible blindness globally, often progressing asymptomatically until advanced stages. Awareness and knowledge of glaucoma are critical determinants of early diagnosis and treatment-seeking behavior. Data on glaucoma awareness in Palestine are scarce. This study aimed to assess the level of awareness, knowledge, and attitudes regarding glaucoma among the general Palestinian population and to identify sociodemographic factors associated with inadequate knowledge.</p><p><strong>Methods: </strong>A population-based cross-sectional study was conducted from December 1 to December 30, 2025, using an online questionnaire distributed to adults (≥18 years) residing in the West Bank and Jerusalem. The questionnaire included sociodemographic information, glaucoma awareness, knowledge, attitudes, and practices. Reliability was assessed using Cronbach's alpha (α = 0.87). Knowledge scores were calculated with a maximum of 8 points; good knowledge was defined as ≥6 correct answers. Data were analyzed using SPSS v23, employing chi-square tests and multivariable logistic regression.</p><p><strong>Results: </strong>A total of 741 participants completed the survey (50.2% male, 49.8% female). Overall, 54% had heard of glaucoma, but only 13.8% demonstrated good knowledge. Prior awareness of glaucoma was the strongest predictor of good knowledge (aOR = 7.89, p < 0.001). Knowledge gaps were notable regarding the asymptomatic nature of early disease (20.9%), irreversible vision loss (57%), and key risk factors including age ≥40 years (49%), family history (44.9%), and diabetes (55.1%). Older adults, rural residents, and individuals with lower educational levels had significantly lower knowledge scores. Only 26.9% of participants reported eye examinations within the preceding year, and screening intentions were associated with better knowledge (p = 0.015).</p><p><strong>Conclusions: </strong>Although awareness of glaucoma is moderate in Palestine, comprehensive knowledge remains low, particularly among high-risk populations. Public health interventions should target education beyond name recognition, emphasizing asymptomatic progression, irreversible vision loss, and risk factors. Integrating glaucoma education into clinical visits and community-based programs may improve early detection and prevent blindness.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1953940"},"PeriodicalIF":2.4,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677483/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149225538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Activating transcription factor 6 is involved in the beneficial effects of growth hormone-releasing hormone antagonists in the corneal endothelium.","authors":"Md Matiur Rahman Sarker, Saikat Fakir, Madan Sigdel, Nektarios Barabutis","doi":"10.3389/fopht.2026.1946815","DOIUrl":"10.3389/fopht.2026.1946815","url":null,"abstract":"<p><p>The corneal endothelium maintains eye transparency through fluid regulation, and its dysfunction has been associated with impaired vision. This study is focused on the possible involvement of activating transcription factor 6 (ATF6) in the beneficial effects of Growth Hormone - Releasing Hormone antagonists (GHRHAnt) in corneal cells. ATF6 is a UPR sensor involved in barrier function, previously shown to exert anti-inflammatory activities. The aim of this study is to evaluate involvement of ATF6 in the effects of GHRHAnt in the corneal endothelium. MTT assay was used to measure the cell viability of ATF6 modulator. We demonstrated the efficient ATF6 manipulation by AA147 and Ceapin-A7, which are specific ATF6 modulators. Western blot analysis was used to detect the protein expression levels. FITC-dextran assay and DCFDA were utilized to measure paracellular permeability and reactive oxygen species generation, respectively. AA147 enhanced Grp94 and BiP expression, both being downstream ATF6 targets, whereas Ceapin-A7 exerted the opposite effects. Then, we investigated the possible involvement of ATF6 in the protective activities of GHRHAnt in the corneal endothelium. ATF6 activation enhanced the protective effects of GHRHAnt by reducing paracellular permeability and ROS generation, while ATF6 inhibition exerted the opposite effects. Our study suggests that ATF6 mediates - at least in part - the beneficial effects of GHRHAnt in the cornea.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1946815"},"PeriodicalIF":2.4,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13661439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149186162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in ophthalmologyPub Date : 2026-09-29eCollection Date: 2026-01-01DOI: 10.3389/fopht.2026.1935053
Adam J Neuhouser, Sarah Skender, Jane Z Spadaro, Alon Kahana
{"title":"Orbital decompression with intraorbital corticosteroid injection during the active phase of thyroid eye disease: outcomes in a real-world cohort.","authors":"Adam J Neuhouser, Sarah Skender, Jane Z Spadaro, Alon Kahana","doi":"10.3389/fopht.2026.1935053","DOIUrl":"https://doi.org/10.3389/fopht.2026.1935053","url":null,"abstract":"<p><strong>Background: </strong>Orbital decompression is an effective surgery for reducing orbital congestion and proptosis for patients with thyroid eye disease (TED). However, it is commonly stated that elective orbital decompression, i.e., for reasons other than compressive optic neuropathy, should await the quiescent phase of the disease. The reason is to avoid inducing a flare-up of the orbitopathy secondary to surgical inflammation. Still, this means that patients with moderate to severe TED who are suffering from symptoms associated with TED must wait months to years before initiating surgical treatment. The purpose of this study is to evaluate the effectiveness of orbital apex decompression combined with intraorbital corticosteroid injection in patients with active TED, defined as Clinical Activity Score (CAS) ≥3.</p><p><strong>Methods: </strong>This retrospective, single-center cohort study included patients with active TED (pre-operative CAS ≥ 3) who underwent single or staged orbital decompression between February 2023 and September 2025. All lateral wall decompressions included an intraorbital injection of a combination triamcinolone and dexamethasone as part of the operative technique. Primary outcomes included change in CAS, change in proptosis, and postoperative disease progression (≥ 2-point increase in CAS at ≥ 8 weeks). Secondary analysis compared outcomes in patients with and without perioperative treatment using disease-modifying therapy (DMT).</p><p><strong>Results: </strong>Thirty-six patients met inclusion criteria; 14 had preoperative dysthyroid optic neuropathy. Mean CAS decreased from 4.7 to 1.6 (Δ -3.1; 95% CI -3.92 to -2.36), and mean proptosis decreased from 22.7 mm to 19.7 mm (Δ -3.0 mm; 95% CI -3.28 to -2.23). One patient with severe TED met criteria for postoperative disease progression. Outcomes were consistent across subgroups regardless of perioperative DMT exposure. No patients developed new-onset diplopia.</p><p><strong>Conclusions: </strong>Orbital decompression combined with intraorbital corticosteroid injection during active TED was associated with clinically meaningful reductions in CAS and proptosis, with infrequent postoperative deterioration and no major surgical complications. These findings provide real-world evidence supporting use of this combined approach during active disease, including in patients without dysthyroid optic neuropathy. These results are specific to a particular surgical technique and to the perioperative management of underlying thyroid status and risk factors associated with TED exacerbation.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1935053"},"PeriodicalIF":2.4,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13658068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149186337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in ophthalmologyPub Date : 2026-09-29eCollection Date: 2026-01-01DOI: 10.3389/fopht.2026.1929961
Cecelia Mans, Safa Ibrahim, Dina Abdelsalam, Andrew G Lee
{"title":"Case Report: Orbital and intracranial inflammatory syndrome in rheumatoid arthritis.","authors":"Cecelia Mans, Safa Ibrahim, Dina Abdelsalam, Andrew G Lee","doi":"10.3389/fopht.2026.1929961","DOIUrl":"https://doi.org/10.3389/fopht.2026.1929961","url":null,"abstract":"<p><strong>Purpose: </strong>To describe a case of rheumatoid arthritis (RA)-associated orbital and intracranial inflammatory disorder (OIID).</p><p><strong>Background: </strong>RA is a systemic autoimmune disease associated with a multitude of extra-articular manifestations. Cigarette smoking increases the risk of RA vasculitis and adversely influences the expression of the proto-oncogene p53 in RA. Although ocular manifestations of RA are well known, orbital and intracranial inflammatory presentations are much less common.</p><p><strong>Case presentation: </strong>A 63-year-old woman with seropositive RA and a significant tobacco smoking history presented with intermittent jaw pain, headache, left temporal tenderness, blurred vision of the left eye, and intermittent diplopia. Serum laboratory studies demonstrated elevated RF and erythrocyte sedimentation rate (ESR). Cranial and orbital magnetic resonance imaging (MRI) showed left orbital apex enhancement with extension into the left cavernous sinus and Meckel cave. The patient improved with intravenous methylprednisolone and high-dose prednisone, but symptoms recurred with each steroid taper. 13 months later, the patient developed new contralateral right-sided orbital inflammation with cavernous sinus and superior orbital fissure involvement.</p><p><strong>Conclusions: </strong>Clinicians should be aware that orbital (e.g., orbital inflammatory pseudotumor) and intracranial presentations may occur in RA in addition to the more common ocular (e.g., scleritis) presentations.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1929961"},"PeriodicalIF":2.4,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13657957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149186373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in ophthalmologyPub Date : 2026-09-28eCollection Date: 2026-01-01DOI: 10.3389/fopht.2026.1917738
Nikola Denda, Sofija Davidović Terzić, Nemanja Maletin, Kristina Veljkov, Aleksandar Rasković, Ljiljana Jovančević, Siniša Babović
{"title":"Posterior segment imaging clues to systemic malignancy: a phenotype-to-confirmation narrative review.","authors":"Nikola Denda, Sofija Davidović Terzić, Nemanja Maletin, Kristina Veljkov, Aleksandar Rasković, Ljiljana Jovančević, Siniša Babović","doi":"10.3389/fopht.2026.1917738","DOIUrl":"https://doi.org/10.3389/fopht.2026.1917738","url":null,"abstract":"<p><p>Systemic malignancies may affect the posterior segment through metastatic, paraneoplastic, hematologic or lymphomatous, and treatment-related mechanisms. Because routine ophthalmic imaging rarely establishes the underlying etiology, its principal clinical value is to identify suspicious patterns, prioritize competing diagnoses, and guide further investigation. This narrative review synthesizes malignancy-related posterior segment findings and proposes a clinically oriented phenotype-to-confirmation framework for multimodal interpretation. A literature search was conducted in PubMed, Scopus, and Web of Science for publications from January 2000 to May 18, 2026. The review included choroidal metastasis, paraneoplastic retinopathies and choroidopathies, vitreoretinal lymphoma, hematologic infiltration, leukemic retinopathy, and anticancer therapy-related toxicity. Owing to heterogeneity in disease entities, imaging protocols, diagnostic confirmation, and study designs, the evidence was synthesized qualitatively. Findings were organized into five suspicion-triggering phenotypes: exudative choroidal mass, RPE-choroidal remodeling, vitreoretinal infiltrative, diffuse neuroretinal dysfunction, and treatment-imprint phenotypes. Each phenotype was linked to its principal mimickers and to appropriate additional investigations, including targeted multimodal imaging, electrophysiology, ocular-fluid analysis, molecular testing, or systemic oncologic reassessment. These phenotypes should not be regarded as validated diagnostic categories, but as clinical entry points for differential exclusion and diagnostic escalation. Artificial intelligence may eventually support image registration, lesion tracking, and longitudinal comparison; however, its role in these rare and heterogeneous disorders remains investigational.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"6 ","pages":"1917738"},"PeriodicalIF":2.4,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13655719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149186405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}